title: Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes.
authors.affiliation: School of Medicine, Belgrade University, Belgrade, Serbia Cardiology Clinic, Clinical Centre of Serbia, Visegradska 26, Belgrade 11000, Serbia tanjapotpara@gmail.com tatjana.potpara@mfub.bg.ac.rs.
authors.forename: Tatjana S
authors.initials: TS
authors.lastname: Potpara
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
authors.forename: Deirdre A
authors.initials: DA
authors.lastname: Lane
authors.affiliation: School of Medicine, Belgrade University, Belgrade, Serbia University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000453:epidemiology*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D012042:Registries; D000069552:Rivaroxaban / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D028761:Withholding Treatment / Q000706:statistics & numerical data*
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban